Brolucizumab for treating neovascular age-related macular degeneration: An alternative for treatment-refractory patients

被引：0
|
作者：
Groen, Martin Biilmann [1 ]
Vestergaard, Anders Hojslet [1 ,2 ]
Cehofski, Lasse Jorgensen [1 ,2 ]
机构：
[1] Odense Univ Hosp, Dept Ophthalmol, Odense, Denmark
[2] Univ Southern Denmark, Clin Inst, Res Unit Ophthalmol, Odense, Denmark
来源：
ACTA OPHTHALMOLOGICA | 2025年
关键词：
D O I：
10.1111/aos.17446
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Advances in the treatment of neovascular age-related macular degeneration
    Lanzetta, Paolo
    EJHP PRACTICE, 2008, 14 (06): : 17 - 20
  • [42] A case of recalcitrant neovascular wet age-related macular degeneration treated with Intravitreal Brolucizumab
    Panigrahi, Pradeep Kumar
    PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY, 2021, 35
  • [43] Real-life experiences with Brolucizumab in recalcitrant neovascular age-related macular degeneration
    Book, Marius
    Ziegler, M.
    Rothaus, K.
    Faatz, H.
    Gutfleisch, M.
    Spital, G.
    Lommatzsch, A.
    Pauleikhoff, D.
    OPHTHALMOLOGE, 2022, 119 (03): : 258 - 264
  • [44] Brolucizumab Versus Aflibercept in Participants with Neovascular Age-Related Macular Degeneration: A Randomized Trial
    Dugel, Pravin U.
    Jaffe, Glenn J.
    Sallstig, Peter
    Warburton, James
    Weichselberger, Andreas
    Wieland, Mark
    Singerman, Lawrence
    OPHTHALMOLOGY, 2017, 124 (09) : 1296 - 1304
  • [45] Real-life experiences with Brolucizumab in recalcitrant neovascular age-related macular degeneration
    Book, Marius
    Ziegler, M.
    Rothaus, K.
    Faatz, H.
    Gutfleisch, M.
    Spital, G.
    Lommatzsch, A.
    Pauleikhoff, D.
    OPHTHALMOLOGIE, 2022, 119 (03): : 258 - 264
  • [46] TREATMENT PREFERENCE DRIVERS OF PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
    Skelly, A.
    Taylor, N.
    Banhazi, J.
    Okede, C.
    VALUE IN HEALTH, 2018, 21 : S433 - S433
  • [47] Short-term outcomes of switching to brolucizumab in japanese patients with neovascular age-related macular degeneration
    Yoko Kitajima
    Maiko Maruyama-Inoue
    Shoko Ikeda
    Arisa Ito
    Tatsuya Inoue
    Yasuo Yanagi
    Kazuaki Kadonosono
    Japanese Journal of Ophthalmology, 2022, 66 : 511 - 517
  • [48] Three-year visual outcomes after brolucizumab in patients with neovascular age-related macular degeneration
    Yume Kobayashi
    Maiko Maruyama-Inoue
    Tatsuya Inoue
    Yasuo Yanagi
    Kazuaki Kadonosono
    BMC Ophthalmology, 25 (1)
  • [49] Short-term outcomes of switching to brolucizumab in japanese patients with neovascular age-related macular degeneration
    Kitajima, Yoko
    Maruyama-Inoue, Maiko
    Ikeda, Shoko
    Ito, Arisa
    Inoue, Tatsuya
    Yanagi, Yasuo
    Kadonosono, Kazuaki
    JAPANESE JOURNAL OF OPHTHALMOLOGY, 2022, 66 (06) : 511 - 517
  • [50] Neovascular Age-Related Macular Degeneration
    Veritti, Daniele
    Sarao, Valentina
    Lanzetta, Paolo
    OPHTHALMOLOGICA, 2012, 227 : 11 - 20
12345